R
4.91
0.37 (8.15%)
| 前收盘价格 | 4.54 |
| 收盘价格 | 4.48 |
| 成交量 | 53,842 |
| 平均成交量 (3个月) | 692,006 |
| 市值 | 3,624,940 |
| 市盈率 (P/E TTM) | 0.019 |
| 价格/销量 (P/S) | 0.290 |
| 股市价格/股市净资产 (P/B) | 30.42 |
| 52周波幅 | |
| 利润日期 | 14 Aug 2025 |
| 营业毛利率 | -48.26% |
| 营业利益率 (TTM) | -165.23% |
| 稀释每股收益 (EPS TTM) | 264.12 |
| 季度收入增长率 (YOY) | -42.70% |
| 总债务/股东权益 (D/E MRQ) | 10.57% |
| 流动比率 (MRQ) | 1.53 |
| 营业现金流 (OCF TTM) | -4.47 M |
| 杠杆自由现金流 (LFCF TTM) | -1.48 M |
| 资产报酬率 (ROA TTM) | -53.50% |
| 股东权益报酬率 (ROE TTM) | -120.16% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | ReShape Lifesciences, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
-0.9
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | -0.93 |
|
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 10.63% |
| 机构持股比例 | 0.73% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合